Development and characterization of mouse anti-canine PD-L1 monoclonal antibodies and their expression in canine tumors by immunohistochemistry in vitro
AbstractImmune escape is the hallmark of carcinogenesis. This widely known mechanism is the overexpression of immune checkpoint ligands, such as programmed cell death protein 1 and programmed death-ligand 1 (PD-1/PD-L1), leading to T cell anergy. Therefore, cancer immunotherapy with specific binding...
Główni autorzy: | Sirintra Sirivisoot, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Phijitra Muanwein, Trairak Pisitkun, Chenphop Sawangmake, Araya Radtanakatikanon, Anudep Rungsipipat |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
Taylor & Francis Group
2023-12-01
|
Seria: | Veterinary Quarterly |
Hasła przedmiotowe: | |
Dostęp online: | https://www.tandfonline.com/doi/10.1080/01652176.2023.2240380 |
Podobne zapisy
-
Quantification of pharmacokinetic profiles of a recombinant canine PD-1 fusion protein by validated sandwich ELISA method
od: Jicheng Qiu, i wsp.
Wydane: (2022-08-01) -
Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
od: Hiroto Takeuchi, i wsp.
Wydane: (2020-06-01) -
Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development
od: Tanapati Phakham, i wsp.
Wydane: (2022-10-01) -
Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors
od: Sho Yoshimoto, i wsp.
Wydane: (2023-12-01) -
Post-Chemotherapy Canine Lymphomatous Lymph Node Observations on B-Mode and Strain Elastographic Ultrasound
od: Somchin Sutthigran, i wsp.
Wydane: (2024-08-01)